| [1] |
Biagioni E, Cavazzuti I, Busani S, et al. Acute renal failure and renal replacement therapy in the postoperative period of orthotopic liver transplant patients versus nonelective abdominal surgery patients[J]. Transplant Proc, 2012, 44(1):309.
|
| [2] |
Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes[J]. Br J Anaesth, 2015, 114(6):919-926.
|
| [3] |
肖巧红，庄永泽. 肝移植术后急性肾损伤的发生率、危险因素及预后分析[C]//中国中西医结合学会肾脏疾病专业委员会2018年学术年会, 重庆, 2018.
|
| [4] |
Durand F, Francoz C, Asrani SK, et al. Acute kidney injury after liver transplantation[J]. Transplantation, 2018, 102(10):1636-1649.
|
| [5] |
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure--definition，outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care, 2004, 8(4):R204-212.
|
| [6] |
de Haan JE, Hoorn EJ, de Geus HRH. Acute kidney injury after liver transplantation: recent insights and future perspectives[J]. Best Pract Res Clin Gastroenterol, 2017, 31(2):161-169.
|
| [7] |
孙丽君，孙海鹏，朱嘉琦, 等. RIFLE、AKIN和KDIGO三种急性肾损伤诊断标准在心脏术后患者中的应用比较[J]. 中国中西医结合肾病杂志, 2014, 15(3):211-215.
|
| [8] |
邓攀，赵于军，王强, 等. 肝移植术后并发急性肾损伤的诊疗进展[J/CD]. 中华移植杂志(电子版), 2020, 14(1):44-48.
|
| [9] |
向丽，卢长江，胡杨科, 等. 心脏死亡器官捐献肝移植术后并发急性肾损伤危险因素分析[J/CD]. 中华移植杂志(电子版), 2020, 14(2):92-95.
|
| [10] |
Yin Z, Li B, Zou F, et al. Risk factors of acute kidney injury after orthotopic liver transplantation in China[J]. Sci Rep, 2017(7):41555.
|
| [11] |
吕海金，易述红，陈艳, 等. 肝移植术后急性肾损伤的危险因素分析[J/CD]. 中华肝脏外科手术学电子杂志, 2013, 2(5):310-313.
|
| [12] |
李喆，尚晨，张志贇, 等. 成人肝移植术后早期急性肾损伤的发生和危险因素分析[J]. 武汉大学学报(医学版), 2020, 41(3):485-489.
|
| [13] |
郑树森，沈恬，徐骁, 等. 中国肝移植受者肾损伤管理专家共识(2017版)[J/CD].中华移植杂志(电子版), 2017, 11(3):130-137.
|
| [14] |
白明传，邬步云，许雪强, 等. 肝移植术后早期急性肾损伤的危险因素及与预后的关系[J/CD]. 中华肾病研究电子杂志, 2020, 9(5):193-201.
|
| [15] |
Park MH, Shim HS, Kim WH, et al. Clinical risk scoring models for prediction of acute kidney injury after living donor liver transplantation: a retrospective observational study[J]. PLoS One, 2015, 10(8):e0136230.
|
| [16] |
向丽，卢长江，吴胜东, 等. 肝移植术后急性肾损伤的研究进展[J/CD]. 实用器官移植电子杂志, 2020, 8(2):137-141.
|
| [17] |
Ma G, Jiang H, Zhang X, et al. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: a propensity score-matched analysis[J]. Liver Transpl, 2015, 21(12):1560.
|
| [18] |
王延庆，韩玉珍，张进, 等. 肝移植术后血清肌红蛋白水平对患者新发急性肾损伤的预测价值[J]. 实用医学杂志, 2021, 37(1):46-50.
|
| [19] |
Durand F. Hot-topic debate on kidney function: renal-sparing approaches are beneficial[J]. Liver Transpl, 2011, 17 Suppl 3:S43-49.
|
| [20] |
Neuberger JM, Mamelok RD, Neuhaus P, et al. Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study[J]. Am J Transplant, 2009, 9(2):327-336.
|
| [21] |
Boudjema K, Camus C, Saliba F, et al. Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study[J]. Am J Transplant, 2011, 11(5):965-976.
|
| [22] |
Teperman L, Moonka D, Sebastian A, et al. Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial[J]. Liver Transpl, 2013, 19(7):675-689.
|
| [23] |
Klintmalm GB, Feng S, Lake JR, et al. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase Ⅱ randomized study[J]. Am J Transplant, 2014, 14(8):1817-1827.
|
| [24] |
王建星，刘亚玲，狄长安. 持续肾替代治疗在肝移植术后急性肾损伤的应用[J]. 中华肝胆外科杂志, 2015, 21(1):39-43.
|
| [25] |
Ren A, Li Z, Zhang X, et al. Optimal timing of initiating CRRT in patients with acute kidney injury after liver transplantation[J]. Ann Transl Med, 2020, 8(21):1361.
|
| [26] |
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study[J]. JAMA, 2005, 294(7):813-818.
|
| [27] |
Pavyde E, Maciulaitis R, Mauricas M, et al. Skeletal muscle-derived stem/progenitor cells: a potential strategy for the treatment of acute kidney injury[J]. Stem Cells Int, 2016:9618480.
|